Results 61 to 70 of about 568,291 (208)

Effect of Shexiang Tongxin dropping pill on stable coronary artery disease patients with normal fractional flow reserve and coronary microvascular disease

Medicine, 2020
Introduction: Coronary microvascular disease (CMVD) can affect the structure, function, and metabolism of the heart, and has an important impact on the occurrence, development and prognosis of coronary artery disease (CAD). Shexiang Tongxin dropping pill
Yanling Lu, Xiaopeng Chu, Jiefang Zhang, Yanbo Zhao, Chong-ying Jin, Junhui Zhu, G. Fu, Fuyu Qiu   +7 more
semanticscholar   +1 more source

Inflammation and Coronary Microvascular Dysfunction in Autoimmune Rheumatic Diseases [PDF]

International Journal of Molecular Sciences, 2019
Autoimmune rheumatic diseases (ARDs) form a heterogeneous group of disorders that include systemic lupus erythematosus (SLE), systemic sclerosis (SSc), rheumatoid arthritis (RA), idiopathic inflammatory myopathies (IIMs), and systemic vasculitis. Coronary microvascular dysfunction (CMD) is quite common in patients with ARDs and is linked to increased ...
Zanatta E., Colombo C., D'amico G., D'humieres T., Dal Lin C., Tona F.   +5 more
openaire   +2 more sources

How to Diagnose and Manage Angina Without Obstructive Coronary Artery Disease: Lessons from the British Heart Foundation CorMicA Trial

Interventional Cardiology: Reviews, Research, Resources, 2019
Patients with symptoms and/or signs of ischaemia but no obstructive coronary artery disease (INOCA) present a diagnostic and therapeutic challenge.
Thomas J Ford, Colin Berry
doaj   +1 more source

Biomarkers and Coronary Microvascular Dysfunction in Women With Angina and No Obstructive Coronary Artery Disease

JACC: Advances, 2023
Background Coronary microvascular dysfunction (CMD) is a major cause of ischemia with no obstructed coronary arteries. Objectives The authors sought to assess protein biomarker signature for CMD.
E. Prescott, K. Bove, D. F. Bechsgaard, B. Shafi, T. Lange, J. Schroder, H. E. Suhrs, R. L. Nielsen   +7 more
semanticscholar   +1 more source

Circulating humoral factors and endothelial progenitor cells in patients with differing coronary collateral support

, 2004
Background - The mechanisms underlying the variation in collateral formation between patients, even with similar patterns of coronary artery disease, remain unclear.
Bucknall, CA, Meng, Y G, Redwood, SR, Pearson, JD, Redwood, S R, Edwards, R J, Lambiase, PD, Marber, MS, Edwards, RJ, Anthopoulos, P, Rahman, S, Lambiase, P D, Meng, YG, Pearson, J D, Marber, M S; id_orcid, Bucknall, C A   +15 more
core   +1 more source

Coronary microvascular dysfunction and cardiovascular disease: Pathogenesis, associations and treatment strategies.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2023
Coronary microvascular dysfunction (CMD) is a high-risk factor for a variety of cardiovascular events. Due to its complex aetiology and concealability, knowledge of the pathophysiological mechanism of CMD is still limited at present, which greatly ...
Zhihua Yang, Yangxi Liu, Zhenzhen Li, Shaoling Feng, Shanshan Lin, Zhao Ge, Yujian Fan, Yi Wang, Xianliang Wang, Jingyuan Mao   +9 more
semanticscholar   +1 more source

Evaluation of coronary microvascular function and nitric oxide synthase intron 4a/b polymorphism in patients with coronary slow flow

, 2013
Objective Slow coronary flow (SCF) is reported to be associated with increased risk of cardiovascular disease. We have used coronary flow reserve measurement by transthoracic Doppler echocardiography to determine coronary microvascular function in ...
KEMALOGLU, Tugba, Ekmekci, Sema S., Abaci, Neslihan, Uestek, Duran, ILHAN, Erkan, GUENGOER, Baris, EKMEKCI, Ahmet, OSMONOV, Damirbek, OEZCAN, Kazim S., EREN, Mehmet   +9 more
core   +1 more source

Coronary microvascular dysfunction. Diagnostics and therapy of non-obstructive coronary diseases

Cardiologia Hungarica
In patients with angina, the ischaemia in the absence of obstructive coronary disease and other heart disease in 30-60% of coronarographies may be due to coronary microvascular dysfunction – coronary microvascular artery disease.
Ipoly Szauder
doaj   +1 more source

Transthoracic Assessment of Coronary Flow Velocity Reserve: A Practical Approach to Diagnostic Testing in Patients with Angina and No Obstructive Coronary Artery Disease

Journal of Interventional Cardiology, 2021
More than half of the patients with symptoms suggestive of myocardial ischemia presenting at invasive angiography have no obstructive coronary artery disease (CAD).
Daria Frestad Bechsgaard, Eva Prescott
doaj   +1 more source

Coronary Microvascular Disease in Women: Epidemiology, Mechanisms, Evaluation, and Treatment.

Canadian Journal of Physiology and Pharmacology
Coronary microvascular dysfunction (CMD) involves functional or structural abnormalities of the coronary microvasculature resulting in dysregulation of coronary blood flow (CBF) in response to myocardial oxygen demand.
R. Steinberg, Anamaria Dragan, P. Mehta, O. Toleva   +3 more
semanticscholar   +1 more source